Cargando…

The Antitumorigenic Function of EGFR in Metastatic Breast Cancer is Regulated by Expression of Mig6

Numerous studies by our lab and others demonstrate that epidermal growth factor receptor (EGFR) plays critical roles in primary breast cancer (BC) initiation, growth and dissemination. However, clinical trials targeting EGFR function in BC have lead to disappointing results. In the current study we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wendt, Michael K., Williams, Whitney K., Pascuzzi, Pete E., Balanis, Nikolas G., Schiemann, Barbara J., Carlin, Cathleen R., Schiemann, William P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309683/ https://www.ncbi.nlm.nih.gov/pubmed/25622905 http://dx.doi.org/10.1016/j.neo.2014.11.009

Ejemplares similares

STAT3 and epithelial–mesenchymal transitions in carcinomas
por: Wendt, Michael K, et al.
Publicado: (2014)

β3 Integrin–EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells
por: Balanis, Nikolas, et al.
Publicado: (2011)

Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
por: Wendt, Michael K., et al.
Publicado: (2011)

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers
por: Wendt, Michael K, et al.
Publicado: (2014)

Mutual cross-talk between fibronectin integrins and the EGF receptor: Molecular basis and biological significance
por: Balanis, Nikolas, et al.
Publicado: (2012)

The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors
por: Chang, Xiaofei, et al.
Publicado: (2013)

Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT
por: Parvani, Jenny G, et al.
Publicado: (2013)

Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition Facilitates Epidermal Growth Factor-Dependent Breast Cancer Progression
por: Wendt, Michael K., et al.
Publicado: (2010)

Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis
por: Wendt, Michael K, et al.
Publicado: (2009)

Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
por: Kang, Da Hyun, et al.
Publicado: (2020)

Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas
por: Meseure, Didier, et al.
Publicado: (2020)

Tipping the balance between good and evil: aberrant 14-3-3ζ expression drives oncogenic TGF-β signaling in metastatic breast cancers
por: Morrison, Chevaun D., et al.
Publicado: (2015)

Introduction to this special issue “Breast Cancer Metastasis”
por: Schiemann, William P.
Publicado: (2020)

lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells
por: Parker, Kimberly A., et al.
Publicado: (2021)

Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
por: Parvani, Jenny G., et al.
Publicado: (2013)

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
por: Pozzi, Ambra, et al.
Publicado: (2008)

The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer
por: Bledzka, Kamila, et al.
Publicado: (2017)

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
por: Huang, Yi-Hsuan, et al.
Publicado: (2022)

PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells
por: Siu, Allan, et al.
Publicado: (2011)

Glucolipotoxic Stress-Induced Mig6 Desensitizes EGFR Signaling and Promotes Pancreatic Beta Cell Death
por: Chen, Yi-Chun, et al.
Publicado: (2023)

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
por: Kerr, Lauren T., et al.
Publicado: (2016)

In vivo Dual Substrate Bioluminescent Imaging
por: Wendt, Michael K., et al.
Publicado: (2011)

Combinatorial control of gene expression by the three yeast repressors Mig1, Mig2 and Mig3
por: Westholm, Jakub Orzechowski, et al.
Publicado: (2008)

Eosinophils Exert Antitumorigenic Effects in the Development of Esophageal Squamous Cell Carcinoma
por: Jacobse, Justin, et al.
Publicado: (2023)

A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation
por: Frosi, Yuri, et al.
Publicado: (2010)

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
por: Moonrin, Ninnutt, et al.
Publicado: (2015)

Intervention of AXL in EGFR Signaling via Phosphorylation and Stabilization of MIG6 in Non-Small Cell Lung Cancer
por: Yang, Ya-Yu, et al.
Publicado: (2023)

ECO/siRNA nanoparticles and breast cancer metastasis
por: Lu, Zheng-Rong, et al.
Publicado: (2015)

The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β
por: Sokol, Jonathan P, et al.
Publicado: (2005)

Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice
por: Ruddy, Jean Marie B., et al.
Publicado: (2002)

Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells
por: YAMAMURO, SHUN, et al.
Publicado: (2015)

Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
por: Donneys, Alexis, et al.
Publicado: (2018)

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness
por: Robinson, Nathaniel J, et al.
Publicado: (2020)

Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression()()
por: Parvani, Jenny G., et al.
Publicado: (2015)

Structure and mechanism of activity-based inhibition of the EGF-Receptor by Mig6
por: Park, Eunyoung, et al.
Publicado: (2015)

Abstract QS12: Deferoxamine Diminishes Breast Cancer Proliferation and Enhances Irradiated Breast Reconstruction: An Antitumorigenic Mechanism Defined
por: Lynn, Jeremy V., et al.
Publicado: (2019)

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
por: O'Donnell, Charlotte, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eol2gigng5hhmgu6rjumd2hv07